Literature DB >> 26243406

Innate detection of hepatitis B and C virus and viral inhibition of the response.

Zhigang Yi1, Jieliang Chen1, Maya Kozlowski1, Zhenghong Yuan1,2.   

Abstract

Viral hepatitis caused by hepatitis B virus (HBV) and hepatitis C virus (HCV) infections poses a significant burden to the public health system. Although HBV and HCV differ in structure and life cycles, they share unique characteristics, such as tropism to infect hepatocytes and association with hepatic and extrahepatic disorders that are of innate immunity nature. In response to HBV and HCV infection, the liver innate immune cells eradicate pathogens by recognizing specific molecules expressed by pathogens via distinct cellular pattern recognition receptors whose triggering activates intracellular signalling pathways inducing cytokines, interferons and anti-viral response genes that collectively function to clear infections. However, HBV and HCV evolve strategies to inactivate innate signalling factors and as such establish persistent infections without being recognized by the innate immunity. We review recent insights into how HBV and HCV are sensed and how they evade innate immunity to establish chronicity. Understanding the mechanisms of viral hepatitis is mandatory to develop effective and safe therapies for eradication of viral hepatitis.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26243406     DOI: 10.1111/cmi.12489

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  5 in total

Review 1.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

2.  Identification of Retinoic Acid Receptor Agonists as Potent Hepatitis B Virus Inhibitors via a Drug Repurposing Screen.

Authors:  Baocun Li; Yang Wang; Fang Shen; Min Wu; Yaming Li; Zhong Fang; Jianyu Ye; Li Wang; Lu Gao; Zhenghong Yuan; Jieliang Chen
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 3.  Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.

Authors:  Suzanne Faure-Dupuy; Julie Lucifora; David Durantel
Journal:  Viruses       Date:  2017-04-28       Impact factor: 5.048

4.  Analysis of TLR7, SOCS1 and ISG15 immune genes expression in the peripheral blood of responder and non-responder patients with chronic Hepatitis C.

Authors:  Razieh Dowran; Jamal Sarvari; Afagh Moattari; Mohammad-Reza Fattahi; Amin Ramezani; Seyed Younes Hosseini
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

Review 5.  Role of miR-223 in the pathophysiology of liver diseases.

Authors:  Dan Ye; Tianbao Zhang; Guohua Lou; Yanning Liu
Journal:  Exp Mol Med       Date:  2018-09-26       Impact factor: 8.718

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.